Liver transplantation

Liver transplantation (LTx) is the only adequate treatment for end-stage liver diseases. On the short-term it is a successful treatment, but long-term patient survival and quality of life is severely impaired by complications caused by continuous immunosuppressive treatment and hepatitis virus re-infection. These clinical problems are the basis of our research. Principal investigators in the lab are dr. Jaap Kwekkeboom and dr. Luc van der Laan. Close interaction with the liver transplant physicians in the Erasmus MC, under supervision of Prof. dr. Herold Metselaar and prof. dr. Hugo Tilanus, ensures that our research has a typically translational character.